313 related articles for article (PubMed ID: 9067710)
1. The utility of a midcycle follicle-stimulating hormone boost in addition to human chorionic gonadotropin for timing of follicle aspiration in unstimulated in vitro fertilization cycles.
Lindheim SR; Sauer MV; Francis MM; Macaso T; Lobo R; Paulson RJ
Gynecol Obstet Invest; 1997; 43(2):76-8. PubMed ID: 9067710
[TBL] [Abstract][Full Text] [Related]
2. Addition of a gonadotropin releasing hormone (GnRH) antagonist and exogenous gonadotropins to unstimulated in vitro fertilization (IVF) cycles: physiologic observations and preliminary experience.
Paulson RJ; Sauer MV; Lobo RA
J Assist Reprod Genet; 1994 Jan; 11(1):28-32. PubMed ID: 7949832
[TBL] [Abstract][Full Text] [Related]
3. The significance of elevated early follicular-phase follicle stimulating hormone (FSH) levels: observations in unstimulated in vitro fertilization cycles.
Lindheim SR; Sauer MV; Francis MM; Macaso TM; Lobo RA; Paulson RJ
J Assist Reprod Genet; 1996 Jan; 13(1):49-52. PubMed ID: 8825167
[TBL] [Abstract][Full Text] [Related]
4. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol (E2) and follicle stimulating hormone (FSH) in in vitro fertilization and embryo transfer.
Kreiner D; Droesch K; Itskovitz J; Liu HC; Navot D; Rosenwaks Z
J In Vitro Fert Embryo Transf; 1988 Oct; 5(5):265-7. PubMed ID: 3148022
[TBL] [Abstract][Full Text] [Related]
6. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
[TBL] [Abstract][Full Text] [Related]
7. A bolus of recombinant human follicle stimulating hormone at midcycle induces periovulatory events following multiple follicular development in macaques.
Zelinski-Wooten MB; Hutchison JS; Hess DL; Wolf DP; Stouffer RL
Hum Reprod; 1998 Mar; 13(3):554-60. PubMed ID: 9572409
[TBL] [Abstract][Full Text] [Related]
8. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K
Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome.
Loumaye E; Engrand P; Howles CM; O'Dea L
Fertil Steril; 1997 May; 67(5):889-99. PubMed ID: 9130895
[TBL] [Abstract][Full Text] [Related]
10. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
Agrawal R; Conway GS; Engmann L; Bekir JS; Jacobs HS
Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
[TBL] [Abstract][Full Text] [Related]
11. In vitro fertilization: determination of follicular maturation for timing of human chorionic gonadotropin administration.
Casper RF; Armstrong DT; Brown SE; Daniel SA; Yuzpe AA; Erskine H
Fertil Steril; 1987 Feb; 47(2):345-9. PubMed ID: 3102289
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group.
Hum Reprod; 1998 Nov; 13(11):3023-31. PubMed ID: 9853849
[TBL] [Abstract][Full Text] [Related]
14. Follicular and estradiol parameters that improve success with natural cycle in vitro fertilization.
DiMattina M; Gordon JD; Botes A; Celia G; Payson M; Graves-Herring J
J Reprod Med; 2014; 59(5-6):267-73. PubMed ID: 24937968
[TBL] [Abstract][Full Text] [Related]
15. The utility of serum progesterone and inhibin A for monitoring natural-cycle IVF-ET.
Lindheim SR; Chang PL; Vidali A; Ferin M; Sauer MV
J Assist Reprod Genet; 1998 Oct; 15(9):538-41. PubMed ID: 9822981
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting pregnancy success of human in-vitro fertilization in unstimulated cycles.
Paulson RJ; Sauer MV; Francis MM; Macaso T; Lobo RA
Hum Reprod; 1994 Aug; 9(8):1571-5. PubMed ID: 7989524
[TBL] [Abstract][Full Text] [Related]
17. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M
Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
[TBL] [Abstract][Full Text] [Related]
18. Timing of oocyte retrieval in cycles with a spontaneous luteinizing hormone surge in a large in vitro fertilization program.
Droesch K; Muasher SJ; Kreiner D; Jones GS; Acosta AA; Rosenwaks Z
Fertil Steril; 1988 Sep; 50(3):451-6. PubMed ID: 3137100
[TBL] [Abstract][Full Text] [Related]
19. Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration.
Propst AM; Hill MJ; Bates GW; Palumbo M; Van Horne AK; Retzloff MG
Fertil Steril; 2011 Oct; 96(4):898-904. PubMed ID: 21839437
[TBL] [Abstract][Full Text] [Related]
20. The empty follicle syndrome: a pharmaceutical industry syndrome.
Zegers-Hochschild F; Fernández E; Mackenna A; Fabres C; Altieri E; Lopez T
Hum Reprod; 1995 Sep; 10(9):2262-5. PubMed ID: 8530648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
